Physician profile
Robert J Erickson
NPI 1093771396
$12,902.45
in general payments reported to CMS, 2019-2025
63 companies · $2,271 in 2025
The $2,271 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,668 · 2020: $1,083 · 2021: $1,092 · 2022: $2,164 · 2023: $2,610 · 2024: $2,014 · 2025: $2,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,894.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,622.30 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,142.08 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $1,017.92 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $907.67 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $857.17 | 2019-2025 | |
| Lilly USA, LLC | $856.19 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Sanofi-Aventis U.S. LLC | $548.42 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $457.80 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $457.37 | 2019-2024 | Octrode, Freestyle Libre 3 |
| Exact Sciences Corporation | $377.07 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $348.38 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.57 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $257.65 | 2019-2024 | Veozah |
| Insulet Corporation | $253.68 | 2019-2025 | Omnipod |
| Pacira Therapeutics, INC. | $245.10 | 2020-2021 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $243.00 | 2019-2024 | Gardasil 9, Verquvo, Gardasil |
| Boston Scientific Corporation | $180.37 | 2023 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $179.46 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $174.47 | 2023-2025 | Rexulti |
| Dexcom, INC. | $162.84 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $146.84 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $145.36 | 2024-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $142.87 | 2020-2023 | Trintellix |
| Silk Road Medical, INC. | $142.86 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Bayer Healthcare Pharmaceuticals INC. | $139.24 | 2022-2024 | |
| Amarin Pharma, INC. | $110.52 | 2020-2023 | |
| Arthrosurface Incorporated | $101.65 | 2019 | |
| Mannkind Corporation | $98.12 | 2022-2023 | Afrezza |
| Phathom Pharmaceuticals, INC. | $95.09 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $88.30 | 2022-2024 | Descovy, Epclusa |
| Axsome Therapeutics, INC. | $84.95 | 2023-2025 | Auvelity |
| Mdd US Operations, LLC | $78.18 | 2019-2020 | |
| Baxter Healthcare | $57.23 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Allergan, INC. | $51.83 | 2019-2020 | |
| Corcept Therapeutics | $49.27 | 2025 | Korlym |
| Indivior INC. | $48.36 | 2020-2025 | Sublocade |
| Verona Pharma, INC. | $47.04 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $45.54 | 2023-2024 | Keveyis |
| Teva Pharmaceuticals USA, INC. | $45.17 | 2022 | |
| Janssen Pharmaceuticals, INC | $44.73 | 2019-2020 | |
| Impel Pharmaceuticals LLC | $40.72 | 2025 | Trudhesa |
| Lundbeck LLC | $39.14 | 2022-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $38.13 | 2022-2023 | Quviviq |
| Mylan Specialty L.P. | $35.61 | 2022-2024 | Yupelri |
| Currax Pharmaceuticals LLC | $35.37 | 2023 | Contrave, Onzetra Xsail |
| Valeritas, INC. | $33.53 | 2019 | |
| Amneal Pharmaceuticals LLC | $30.39 | 2023-2024 | Unithroid |
| Horizon Therapeutics Plc | $28.27 | 2019 | |
| Alkermes, INC. | $27.46 | 2019-2024 | Vivitrol |
| Beta Bionics, INC. | $23.61 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Impel Pharmaceuticals INC. | $22.20 | 2023 | Trudhesa |
| Edwards Lifesciences Corporation | $21.85 | 2023 | Sapien 3 Ultra Resilia |
| Sumitomo Pharma America, INC. | $21.36 | 2024 | Gemtesa |
| Uswm, LLC | $19.89 | 2021 | |
| Sanofi Pasteur INC. | $19.14 | 2020 | |
| Grifols USA, LLC | $18.84 | 2024 | Prolastin-C Liquid |
| Medtronic, INC. | $17.33 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.46 | 2023 | |
| Scilex Pharmaceuticals INC. | $14.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.59 | 2023 | Eliquis |
| Esperion Therapeutics, INC. | $13.70 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.30 | 2021 | |
| Daiichi Sankyo INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.